Title of article :
Nebivolol prevents remodeling in a rat myocardial infarction model: an echocardiographic study
Author/Authors :
Mercanoğlu, Güldem Olguner Yeditepe University - Faculty of Pharmacy - Department of Pharmacology, Turkey , Pamukçu, Burak Istanbul University - İstanbul Medical Faculty - Department of Cardiology, Turkey , Safran, Nurhas Istanbul University - İstanbul Medical Faculty - Department of Microbiology, Turkey , Mercanoğlu, Fehmi Istanbul University - İstanbul Medical Faculty - Department of Cardiology, Turkey , Fici, Francesco University of Naples - Excellence Research Center for Cardiovascular Disease - Department of Experimental Medicine, Italy , Güngör, Mehmet Istanbul University - İstanbul Medical Faculty - Department of Pharmacology and Clinical Pharmacology, Turkey
From page :
18
To page :
27
Abstract :
Objective: Ventricular remodeling (VR) which develops after myocardial infarction (MI) plays an important role in progressive left ventricular dysfunction. We aimed to investigate the role of nebivolol treatment on VR after a MI in a rat ischemia-reperfusion model. Methods: Rats were divided into 3 groups of 12 each: sham operated (sham-control), MI-induced (MI-control) and nebivolol treated (MI-nebivolol). Left ventricular (LV) diameters, volumes, and diastolic filling parameters were evaluated by echocardiography. On the 28th day, after recording the systemic and LV pressures and determining the plasma nitric oxide (NO) and peroxynitrite (ONOO-) levels , animals were sacrificed and heart, body and LV weights (HW, BW, LVW) were measured and infarct sizes were determined. Results were evaluated statistically by ANOVA for repeated measurements 3x3 factorial design with post-hoc Bonferroni test. Results: After MI, while VR (an increase in LV diameters and volumes associated with a decrease in EF, FS and posterior wall thickness change (LWPc) was significant in MI-control rats (p 0.05 for; all comparisons) these changes were significantly less in MI-nebivolol group (p=0.08 and p=0.06 for EF and FS respectively). LV end diastolic pres-sure (LVEDP) was lower (p 0.005) and Δ±dp/dt’s (p 0.05) were higher in MI-nebivolol group compared to MI-control animals. Although infarct sizes were similar in MI-induced groups (p=0.79); LVW/HW and HW/BW’s were significantly greater in the MI-control group compared to sham-control (p 0.01 for all comparisons), these changes were not statistically significant in MI-nebivolol group. The increase in plasma NO and ONOO- levels were also prevented with nebivolol. Conclusion: Nebivolol therapy reduced the effects of VR in rats after MI. These beneficial effects were not related to its heart rate and blood pressure reducing effects. Nitric oxide regulatory action of this compound may contribute these beneficial effects on VR developed after MI. (Anadolu Kardiyol Derg 2010; 10: 18-27)
Keywords :
Myocardial infarction , ventricular remodeling , nebivolol , echocardiography , nitric oxide , peroxynitrite , left ventricular function
Journal title :
The Anatolian Journal of Cardiology: Andolu Kardiyoloji Dergisi
Journal title :
The Anatolian Journal of Cardiology: Andolu Kardiyoloji Dergisi
Record number :
2691325
Link To Document :
بازگشت